---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-082364"
form_type: "8-K"
ticker: "SEM"
cik: "0001320414"
company_name: "SELECT MEDICAL HOLDINGS CORP"
filed_at: "2023-07-19T23:59:59+00:00"
generated_at: "2026-06-13T06:17:31.792345+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Select Medical Q2 estimates: revenue ~$1.67B, Adj EBITDA ~$219M, EPS ~$0.61; in refinancing talks

## Summary
- Net operating revenue expected ~$1.67B for Q2 ended June 30, 2023.
- Adjusted EBITDA ~$219M; fully diluted EPS ~$0.61.
- As of June 30, 2023, cash ~$100M; indebtedness ~$3.75B.
- Company in discussions with lenders regarding proposed refinancing of certain debt.
- Actual Q2 results to be announced after market close on August 3, 2023.

## SEC filing metadata
- accession: 0001104659-23-082364
- form_type: 8-K
- ticker: SEM
- cik: 0001320414
- company_name: SELECT MEDICAL HOLDINGS CORP
- filed_at: 2023-07-19T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1320414/000110465923082364/0001104659-23-082364-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1320414/000110465923082364/tm2321598d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-082364
- JSON: https://secwatch.observer/filing/0001104659-23-082364.json
- Plain text: https://secwatch.observer/filing/0001104659-23-082364.txt

## Key facts
- Earnings Releases
  SELECT MEDICAL HOLDINGS CORP reported second quarter ended June 30, 2023 results: revenue approximately $1.67 billion, EPS approximately $0.61.
  - Period: second quarter ended June 30, 2023
  - Revenue: approximately $1.67 billion
  - EPS: approximately $0.61
  - Result: preliminary results
  source text: Select Medical expects its net operating revenue for its second quarter of 2023 to be approximately $1.67 billion. Select Medical expects earnings excluding interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, gain (loss) on sale of businesses, and equity in earnings (losses) of unconsolidated subsidiaries, or Adjusted EBITDA, for the second quarter of 2023 to be approximately $219 million. Select Medical expects fully diluted earnings per common share for the second quarter of 2023 to be approximately $0.61.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1320414/000110465923082364/0001104659-23-082364-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.